Literature DB >> 7284376

Mechanism of eukaryotic protein synthesis inhibition by brusatol.

W Willingham, E A Stafford, S H Reynolds, S G Chaney, K H Lee, M Okano, I H Hall.   

Abstract

The mechanism by which brusatol inhibits protein synthesis in rabbit reticulocytes has been investigated. When added to reticulocyte lysates, brusatol inhibits endogenous protein synthesis only after a lag of 2-4 min at 30 degrees C. During this period 80 S ribosomes accumulate. Brusatol is equally effective in inhibiting endogenous protein synthesis in lysates and poly(U)-directed polyphenylalanine synthesis with runoff ribosomes. In fractionated reticulocyte systems, brusatol does not inhibit formation of the ternary, 40 S, and 80 S initiation complexes, but does inhibit the reaction of puromycin with initiation complexes containing [35S]Met-tRNAf. These data suggest that brusatol inhibits the peptidyl transferase elongation reaction of protein synthesis, but can do so only after one round of protein synthesis has been completed. Thus, the mechanism of action of brusatol in the rabbit reticulocyte system is very similar to the effects previously reported for bruceantin in a yeast system.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7284376     DOI: 10.1016/0005-2787(81)90168-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Antitumor Agents. 282. 2'-(R)-O-acetylglaucarubinone, a quassinoid from Odyendyea gabonensis as a potential anti-breast and anti-ovarian cancer agent.

Authors:  Yoshihide Usami; Kyoko Nakagawa-Goto; Jing-Yu Lang; Yoon Kim; Chin-Yu Lai; Masuo Goto; Nobuko Sakurai; Masahiko Taniguchi; Toshiyuki Akiyama; Susan L Morris-Natschke; Kenneth F Bastow; Gordon Cragg; David J Newman; Mihoyo Fujitake; Koichi Takeya; Mien-Chie Hung; Eva Y-H P Lee; Kuo-Hsiung Lee
Journal:  J Nat Prod       Date:  2010-09-24       Impact factor: 4.050

2.  Brusatol overcomes chemoresistance through inhibition of protein translation.

Authors:  Bryan Harder; Wang Tian; James J La Clair; Aik-Choon Tan; Aikseng Ooi; Eli Chapman; Donna D Zhang
Journal:  Mol Carcinog       Date:  2017-02-08       Impact factor: 4.784

3.  Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism.

Authors:  Dongmei Ren; Nicole F Villeneuve; Tao Jiang; Tongde Wu; Alexandria Lau; Henry A Toppin; Donna D Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-04       Impact factor: 11.205

4.  The role of natural products in revealing NRF2 function.

Authors:  Donna D Zhang; Eli Chapman
Journal:  Nat Prod Rep       Date:  2020-05-13       Impact factor: 13.423

5.  Application of Mass Spectrometry Profiling to Establish Brusatol as an Inhibitor of Global Protein Synthesis.

Authors:  Steffan Vartanian; Taylur P Ma; James Lee; Peter M Haverty; Donald S Kirkpatrick; Kebing Yu; David Stokoe
Journal:  Mol Cell Proteomics       Date:  2015-12-28       Impact factor: 5.911

6.  DCB-3503, a tylophorine analog, inhibits protein synthesis through a novel mechanism.

Authors:  Ying Wang; Wenli Gao; Yuri V Svitkin; Annie Pei-Chun Chen; Yung-Chi Cheng
Journal:  PLoS One       Date:  2010-07-15       Impact factor: 3.240

7.  Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2.

Authors:  Adedamola Olayanju; Ian M Copple; Holly K Bryan; George T Edge; Rowena L Sison; Min Wei Wong; Zheng-Quan Lai; Zhi-Xiu Lin; Karen Dunn; Christopher M Sanderson; Ahmad F Alghanem; Michael J Cross; Ewa C Ellis; Magnus Ingelman-Sundberg; Hassan Z Malik; Neil R Kitteringham; Christopher E Goldring; B Kevin Park
Journal:  Free Radic Biol Med       Date:  2014-11-14       Impact factor: 7.376

8.  Brusatol inhibits HIF-1 signaling pathway and suppresses glucose uptake under hypoxic conditions in HCT116 cells.

Authors:  Yapeng Lu; Bo Wang; Qian Shi; Xueting Wang; Dang Wang; Li Zhu
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

9.  Eurycomalactone Inhibits Expression of Endothelial Adhesion Molecules at a Post-Transcriptional Level.

Authors:  Clemens Malainer; Daniel Schachner; Enrico Sangiovanni; Atanas G Atanasov; Stefan Schwaiger; Hermann Stuppner; Elke H Heiss; Verena M Dirsch
Journal:  J Nat Prod       Date:  2017-11-17       Impact factor: 4.050

10.  Altering chemosensitivity by modulating translation elongation.

Authors:  Francis Robert; Marilyn Carrier; Svea Rawe; Samuel Chen; Scott Lowe; Jerry Pelletier
Journal:  PLoS One       Date:  2009-05-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.